Palbociclib Capsules125 mg, Ibrance Price

 Palbociclib is the generic name for the medication sold under the brand name Ibrance. It is a medication used to treat certain types of breast cancer, and it works by inhibiting proteins called cyclin-dependent kinases, which help to regulate cell growth and division.

The price of Ibrance or Palbociclib 125mg can vary depending on several factors, including the country or region where it is being sold, the manufacturer, and the specific pharmacy or hospital where it is being purchased.

In the United States, for example, the cost of Ibrance can range from around $11,000 to $13,000 per month, depending on the dosage and the patient's insurance coverage. However, many patients may be eligible for financial assistance or discounts through the drug manufacturer or other programs.

In other countries, the cost of Palbociclib or Ibrance may be lower or higher, depending on local regulations, pricing policies, and availability.

It is important to note that the cost of Palbociclib or Ibrance may be covered by health insurance, including Medicare and Medicaid, depending on the patient's specific plan and the reason for the treatment. Patients should check with their healthcare provider and insurance company to determine their coverage options and out-of-pocket costs.